Takeda Pharmaceutical Company Limited (TKPHF) is expected to report earnings on Thursday, October 29, 2026, after the close. Consensus EPS estimate is $0.29.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $0.33 | $0.44 | +31.8% | $7.50B |
| 2026-05-26 | FY2026 Q1 | $-0.15 | $-0.10 | +35.2% | $6.89B |
| 2025-06-25 | FY2025 Q1 | $0.34 | $0.55 | +60.2% | $7.68B |
| 2024-06-30 | FY2024 Q2 | $0.24 | $0.41 | +72.1% | $7.50B |
| 2023-09-30 | FY2023 Q3 | $0.32 | $-0.21 | -165.6% | $6.98B |
| 2023-05-30 | FY2023 Q1 | $0.10 | $0.14 | +40.4% | $7.20B |
| 2022-12-31 | FY2022 Q4 | $0.57 | $0.59 | +3.7% | $8.36B |
| 2022-06-29 | FY2022 Q2 | $0.59 | $0.50 | -15.6% | $7.16B |
TKPHF has beaten consensus EPS in 6 of its last 8 reported quarters.
See TKPHF on the live calendar →